Entry |
|
Name |
Uprifosbuvir (USAN/INN) |
Formula |
C22H29ClN3O9P
|
Exact mass |
545.1330
|
Mol weight |
545.90
|
Structure |

|
Simcomp |
|
Class |
Antiviral
DG03198 Anti-HCV agent
DG02000 HCV NS5B polymerase inhibitor
|
Efficacy |
Antiviral, NS5B polymerase inhibitor |
Comment |
Treatment of hepatitis C
|
Target |
HCV NS5B polymerase [KO: K22472] |
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antiviral
DG03198 Anti-HCV agent
DG02000 HCV NS5B polymerase inhibitor
D10996 Uprifosbuvir
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HCV NS5A/NS5B inhibitor
D10996 Uprifosbuvir (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 36
1 C1a C 8.9600 -23.1700
2 C1c C 10.2200 -23.8700
3 O7a O 11.4100 -23.1700
4 C7a C 12.6000 -23.8700
5 C1c C 13.8600 -23.1700
6 N1b N 15.0500 -23.8700
7 P1b P 16.5200 -23.1700
8 C1a C 10.2200 -25.2700
9 O6a O 12.6000 -25.2700
10 C1a C 13.8600 -21.7700
11 O2b O 17.9900 -23.8700
12 O2b O 17.7800 -22.4700
13 O3b O 15.3300 -22.4700
14 C8y C 17.7800 -21.0700
15 C8x C 18.9700 -20.3700
16 C8x C 18.9700 -18.9700
17 C8x C 17.7800 -18.2700
18 C8x C 16.5200 -18.9700
19 C8x C 16.5200 -20.3700
20 C1b C 19.1800 -23.1700
21 C1y C 20.3700 -23.8700
22 C1y C 20.7900 -25.2000
23 C1z C 22.1900 -25.2000
24 C1y C 22.6100 -23.8700
25 O2x O 21.4900 -23.0300
26 O1a O 19.9624 -26.3292
27 C1a C 23.5423 -25.5623
28 X Cl 21.8277 -26.5523
29 N4y N 23.9430 -23.4420
30 C8x C 25.1554 -24.1420
31 C8x C 26.3678 -23.4420
32 C8y C 26.3678 -22.0420
33 N4x N 25.1554 -21.3420
34 C8y C 23.9430 -22.0420
35 O5x O 22.7318 -21.3427
36 O5x O 27.5932 -21.3343
BOND 38
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 7 6 1 #Down
7 2 8 1
8 4 9 2
9 5 10 1 #Up
10 7 11 1 #Up
11 7 12 1
12 7 13 2
13 12 14 1
14 14 15 2
15 15 16 1
16 16 17 2
17 17 18 1
18 18 19 2
19 14 19 1
20 11 20 1
21 21 20 1 #Up
22 22 23 1
23 23 24 1
24 24 25 1
25 25 21 1
26 21 22 1
27 22 26 1 #Down
28 23 27 1 #Up
29 23 28 1 #Down
30 24 29 1 #Up
31 29 30 1
32 30 31 2
33 31 32 1
34 32 33 1
35 33 34 1
36 29 34 1
37 34 35 2
38 32 36 2
|